No Data
Hong Kong stock morning report | The USA fires the first shot in a comprehensive trade war, the three major US stock indices fall while Chinese concept stocks rise against the trend.
① The USA's tariff measures against Mexico and Canada officially took effect on Tuesday, after which both Canada and Mexico launched a comprehensive counterattack. The US Secretary of Commerce stated that Trump is considering reducing some tariffs on Mexico and Canada. ② China has continuously introduced countermeasures against the USA. ③ Zelensky stated he is ready to sign agreements with the USA regarding minerals and security at any time. ④ The three major US stock indexes fell on Tuesday, while most China Concept Stocks rose against the trend.
Yunkang Group (02325) issues a profit warning, expecting a net loss of approximately 0.663 billion to 0.856 billion yuan for the fiscal year 2024.
YunKang Group (02325) announced that the group expects to incur a net loss for the year ending December 31, 2024...
Express News | Yunkang Group - Expected Result Due to Proportion of R&D Expenses to Sales Revenue Further Increased, Others
Express News | Yunkang Group Sees Net Loss RMB663.0 Mln to RMB856.0 Mln for Year
YUNKANG GROUP: PROFIT WARNING
The "DeepSeek Moment" of medicine, has China’s Innovative Drugs also reached it?
Over the past four years, China's share of Global large-scale pharmaceutical Trade has surged from 5% to 30%. From research and development innovation to international mergers and acquisitions, Chinese Innovative Drugs companies are reshaping the Global pharmaceutical innovation landscape.
